Recent Developments and Prospects for Influenza M2 Ion Channel Inhibitors That Circumvent Amantadine Resistance

ISSN: 2212-392X (Online)
ISSN: 1574-8936 (Print)


Volume 11, 5 Issues, 2016


Download PDF Flyer




Current Bioinformatics

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Yi-Ping Phoebe Chen
Department of Computer Science and Information Technology
La Trobe University
Melbourne
Australia


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 0.921
5 - Year: 1.045

Recent Developments and Prospects for Influenza M2 Ion Channel Inhibitors That Circumvent Amantadine Resistance



Current Bioinformatics, Volume 8 (E-pub ahead of print)

Author(s): Petar M Mitrasinovic.


Abstract

Amantadine is a specific anti-influenza A drug that inhibits viral replication by binding to the M2 channel and preventing proton conductance. The increasing resistance to amantadine in strains of the influenza A virus that infect both animals and humans has been highlighted frequently. Resistance is usually caused by one of several single mutations in the M2 channel, but variants with double mutations have also been reported. Attempts to develop alternative inhibitors of the M2 channel that are effective against the resistant mutants have been unsuccessful, mainly because of the lack of information on the precise mode of inhibitor binding. This review summarizes the advances made in determining the mechanisms of action of amantadine and the development of novel inhibitors of the M2 channel during the past 2 years.


Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 8
First Page:
Page Count:
DOI: 10.2174/15748936113089990005
Advertisement
Global Biotechnology Congress 2016Drug Discovery and Therapy World Congress 2016

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science